BioengineeringbioRxivPreprint
Development of 3-in-1 nanotherapeutic strategies for ovarian cancer
Emma Durocher, Sean McGrath, Esha Gahunia…·Suresh Gadde
This paper develops a 3-in-1 nanotherapeutic approach combining cisplatin, olaparib, and metformin for ovarian cancer, showing stability and enhanced therapeutic effects in vitro.
DOI 10.1101/2024.07.17.604002